An update on primary sclerosing cholangitis

From pathogenesis to treatment

M. H. Imam, J. A. Talwalkar, K. D. Lindor

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology despite advances in medical research that have focused on uncovering its pathogenesis. Recent developments in the diagnosis of PSC including technological advances in magnetic resonanace cholangiography and the recognition of distinct clinical subtypes have led to more frequent early detection and appropriate therapy when indicated. Continued work in the areas of identifying genetic predisposing factors and novel molecular therapeutic targets are expected to create new opportunities for treating patients suffering from this chronic illness. In this review we highlight recent advances in PSC pathogenesis, diagnosis and management.

Original languageEnglish (US)
Pages (from-to)49-58
Number of pages10
JournalMinerva Gastroenterologica e Dietologica
Volume59
Issue number1
StatePublished - Mar 2013

Fingerprint

Sclerosing Cholangitis
Cholangiography
Causality
Biomedical Research
Liver Diseases
Chronic Disease
Therapeutics

Keywords

  • Liver
  • Magnetic resonance spectroscopy
  • Primary sclerosing cholangitis

ASJC Scopus subject areas

  • Gastroenterology
  • Internal Medicine
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism

Cite this

An update on primary sclerosing cholangitis : From pathogenesis to treatment. / Imam, M. H.; Talwalkar, J. A.; Lindor, K. D.

In: Minerva Gastroenterologica e Dietologica, Vol. 59, No. 1, 03.2013, p. 49-58.

Research output: Contribution to journalArticle

Imam, M. H. ; Talwalkar, J. A. ; Lindor, K. D. / An update on primary sclerosing cholangitis : From pathogenesis to treatment. In: Minerva Gastroenterologica e Dietologica. 2013 ; Vol. 59, No. 1. pp. 49-58.
@article{dc0d522b699549788598e979288905c6,
title = "An update on primary sclerosing cholangitis: From pathogenesis to treatment",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology despite advances in medical research that have focused on uncovering its pathogenesis. Recent developments in the diagnosis of PSC including technological advances in magnetic resonanace cholangiography and the recognition of distinct clinical subtypes have led to more frequent early detection and appropriate therapy when indicated. Continued work in the areas of identifying genetic predisposing factors and novel molecular therapeutic targets are expected to create new opportunities for treating patients suffering from this chronic illness. In this review we highlight recent advances in PSC pathogenesis, diagnosis and management.",
keywords = "Liver, Magnetic resonance spectroscopy, Primary sclerosing cholangitis",
author = "Imam, {M. H.} and Talwalkar, {J. A.} and Lindor, {K. D.}",
year = "2013",
month = "3",
language = "English (US)",
volume = "59",
pages = "49--58",
journal = "Minerva Gastroenterologica",
issn = "0026-4776",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - An update on primary sclerosing cholangitis

T2 - From pathogenesis to treatment

AU - Imam, M. H.

AU - Talwalkar, J. A.

AU - Lindor, K. D.

PY - 2013/3

Y1 - 2013/3

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology despite advances in medical research that have focused on uncovering its pathogenesis. Recent developments in the diagnosis of PSC including technological advances in magnetic resonanace cholangiography and the recognition of distinct clinical subtypes have led to more frequent early detection and appropriate therapy when indicated. Continued work in the areas of identifying genetic predisposing factors and novel molecular therapeutic targets are expected to create new opportunities for treating patients suffering from this chronic illness. In this review we highlight recent advances in PSC pathogenesis, diagnosis and management.

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology despite advances in medical research that have focused on uncovering its pathogenesis. Recent developments in the diagnosis of PSC including technological advances in magnetic resonanace cholangiography and the recognition of distinct clinical subtypes have led to more frequent early detection and appropriate therapy when indicated. Continued work in the areas of identifying genetic predisposing factors and novel molecular therapeutic targets are expected to create new opportunities for treating patients suffering from this chronic illness. In this review we highlight recent advances in PSC pathogenesis, diagnosis and management.

KW - Liver

KW - Magnetic resonance spectroscopy

KW - Primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=84876578080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876578080&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 49

EP - 58

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

SN - 0026-4776

IS - 1

ER -